跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
Approved
THERAPEUTIC
THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
Thymoorgan Pharmazie GmbH
🇸🇬 Health Sciences Authority
Approval Date
Jun 20, 2024
Approval ID
3bb50e83196ec710
Company
Thymoorgan Pharmazie GmbH
Type
Therapeutic
Approval Details
Approval Id
3bb50e83196ec710
Drug Name
THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
Product Name
THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
Approval Number
SIN17028P
Approval Date
2024-06-20
Registrant
NYPRAX PHARMA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01AC01
Pharma Manufacturer Name
NYPRAX PHARMA PTE. LTD.
Company Detail Path
/organization/nyprax-pharma-pte-ltd
Active Ingredients
Thiotepa
100.0 mg/vial
Thiotepa
100.0 mg/vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 20, 2024
Approval ID
3bb50e83196ec710
Type
Therapeutic
Back to HSA Approvals
THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL - HSA Drug Approval Details
